MENU
GLSI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Greenwich LifeSciences (GLSI) Earnings Date & Reports
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences... Show more
A.I. Advisor
published Earnings
GLSI is expected to report earnings to fall 9.09% to -30 cents per share on November 13
Q3'26
Est.
$-0.30
Q2'26
Est.
$-0.34
Q1'26
Est.
$-0.33
Q4'25
Beat
by $0.02
Q3'25
Missed
by $0.10
The last earnings report on August 17 showed earnings per share of -33 cents, beating the estimate of -33 cents. With 351.00 shares outstanding, the current market capitalization sits at 241.60M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
3992 Bluebonnet Drive
Phone
+1 832 819-3232
Employees
13
Web
https://www.greenwichlifesciences.com